Literature DB >> 33567654

Pathological Circulating Factors in Moyamoya Disease.

Yao-Ching Fang1, Ling-Fei Wei1, Chaur-Jong Hu1,2, Yong-Kwang Tu1,2.   

Abstract

Moyamoya disease (MMD) is a cerebrovascular disease that presents with vascular stenosis and a hazy network of collateral formations in angiography. However, the detailed pathogenic pathway remains unknown. Studies have indicated that in addition to variations in the of genetic factor RNF213, unusual circulating angiogenetic factors observed in patients with MMD may play a critical role in producing "Moyamoya vessels". Circulating angiogenetic factors, such as growth factors, vascular progenitor cells, cytokines, inflammatory factors, and other circulating proteins, could promote intimal hyperplasia in vessels and excessive collateral formation with defect structures through endothelial hyperplasia, smooth muscle migration, and atypical neovascularization. This study summarizes the hypothesized pathophysiology of how these circulating factors affect MMD and the interactive modulation between them.

Entities:  

Keywords:  Moyamoya disease; RNF213; cerebrovascular disease; circulating factor; collateral formations; growth factors

Mesh:

Substances:

Year:  2021        PMID: 33567654      PMCID: PMC7915927          DOI: 10.3390/ijms22041696

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  51 in total

Review 1.  Review of past research and current concepts on the etiology of moyamoya disease.

Authors:  Kiyohiro Houkin; Masaki Ito; Taku Sugiyama; Hideo Shichinohe; Naoki Nakayama; Ken Kazumata; Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

2.  Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene.

Authors:  Ryuichi Morishita; Minako Sakaki; Kei Yamamoto; Sota Iguchi; Motokuni Aoki; Keita Yamasaki; Kunio Matsumoto; Toshikazu Nakamura; Richard Lawn; Toshio Ogihara; Yasufumi Kaneda
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

3.  Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease.

Authors:  A Noda; Y Suzuki; M Takayasu; K Watanabe; T Takagi; M Hara; J Yoshida
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

4.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

5.  Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.

Authors:  Ji Yeoun Lee; Youn Joo Moon; Hae-Ock Lee; Ae-Kyung Park; Seung-Ah Choi; Kyu-Chang Wang; Jung Woo Han; Je-Gun Joung; Hyun Seung Kang; Jeong Eun Kim; Ji Hoon Phi; Woong-Yang Park; Seung-Ki Kim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-05-28       Impact factor: 8.311

6.  Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.

Authors:  Neysan Rafat; Grietje Ch Beck; Pablo G Peña-Tapia; Peter Schmiedek; Peter Vajkoczy
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

7.  Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease.

Authors:  Seung-Ki Kim; Jong-Il Yoo; Byung-Kyu Cho; Soo Jin Hong; Yong-Kook Kim; Jung-Ae Moon; Ji Ha Kim; You-Nam Chung; Kyu-Chang Wang
Journal:  Stroke       Date:  2003-11-06       Impact factor: 7.914

8.  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.

Authors:  M Hojo; M Hoshimaru; S Miyamoto; W Taki; I Nagata; M Asahi; N Matsuura; R Ishizaki; H Kikuchi; N Hashimoto
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

9.  Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.

Authors:  Kinga G Blecharz-Lang; Vincent Prinz; Małgorzata Burek; Dietmar Frey; Tobias Schenkel; Susanne M Krug; Michael Fromm; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-10       Impact factor: 6.200

10.  Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.

Authors:  Haruto Uchino; Masaki Ito; Ken Kazumata; Yuka Hama; Shuji Hamauchi; Shunsuke Terasaka; Hidenao Sasaki; Kiyohiro Houkin
Journal:  BMC Med Genomics       Date:  2018-08-29       Impact factor: 3.063

View more
  2 in total

1.  Editorial for "Pre-Surgical Magnetic Resonance Imaging Indicators of Revascularization Response in Adults With Moyamoya Vasculopathy".

Authors:  Yibin Xie
Journal:  J Magn Reson Imaging       Date:  2022-03-17       Impact factor: 5.119

2.  Construction of Diagnosis Model of Moyamoya Disease Based on Convolution Neural Network Algorithm.

Authors:  Xiangcheng Hao; Li Xu; Yin Liu; Cheng Luo; Yiming Yin; Xiao Chen; Xiaoyang Tao
Journal:  Comput Math Methods Med       Date:  2022-07-25       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.